Wolframin mutations and hospitalization for psychiatric illness

Area of Science:

• Genetics
• Psychiatry
• Molecular Biology

Background:

• Genetic predisposition is crucial in common psychiatric disorders.
• Wolframin gene mutations are linked to mental illness, with Wolfram syndrome (WS) patients exhibiting severe psychiatric symptoms.
• Heterozygous carriers of wolframin mutations are relatively frequent in the population.

Purpose of the Study:

• To test the hypothesis that heterozygous carriers of a wolframin mutation are predisposed to psychiatric illness.
• To investigate the association between wolframin gene mutations and psychiatric hospitalizations in families with Wolfram syndrome.

Main Methods:

• Genotyping and mutation analysis were performed on relatives from 25 Wolfram syndrome families.
• Subjects with psychiatric hospitalizations were assessed for the presence of wolframin mutations.
• Comparison of mutation carrier status in psychiatrically hospitalized relatives versus expected prevalence.

Main Results:

• Eight out of 11 psychiatrically hospitalized relatives carried the family's wolframin mutation, significantly higher than expected (P=0.0022).
• All eight mutation-positive subjects had been hospitalized for major depression.
• The relative risk of psychiatric hospitalization for depression was 7.1 for single wolframin mutation carriers compared to non-carriers.

Conclusions:

• Heterozygous carriers of wolframin mutations have a significantly increased predisposition to psychiatric illness, specifically major depression.
• The wolframin gene is a potential genetic factor contributing to psychiatric disorders in the general population.
• These findings support the role of wolframin gene mutations in the etiology of psychiatric conditions and suggest implications for genetic counseling and management.